Premier Fund Managers’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-10,696
Closed -$350K 206
2024
Q1
$350K Sell
10,696
-1,753
-14% -$55.9K 0.01% 178
2023
Q4
$417K Sell
12,449
-9,326
-43% -$264K 0.02% 167
2023
Q3
$595K Sell
21,775
-13,310
-38% -$370K 0.03% 147
2023
Q2
$1.06M Hold
35,085
0.04% 144
2023
Q1
$1.12M Buy
+35,085
New +$1.11M 0.04% 160
2021
Q2
Sell
-10,000
Closed -$200K 225
2021
Q1
$200K Buy
+10,000
New +$190K 0.01% 212

Other funds holding EVH

Premier Fund Managers's EVH Position: Q2 2024 in Review

Premier Fund Managers sold out of Evolent Health (EVH) in Q2 2024, closing a stake of 10,696 shares — an estimated $350K sold.

Premier Fund Managers first reported a position in EVH in Q1 2021 and held it in 6 quarters. The position peaked at $1.12M in Q1 2023. 243 funds tracked by Wall St. Rank hold EVH as of Q2 2024.

  • Premier Fund Managers reported no remaining Evolent Health position as of Q2 2024 after selling out during the quarter.
  • Premier Fund Managers sold 10,696 Evolent Health shares in Q2 2024, an estimated $350K.
  • Premier Fund Managers first reported a position in Evolent Health in Q1 2021 and held it in 6 quarters.
  • Premier Fund Managers's Evolent Health position peaked at $1.12M in Q1 2023.
  • 243 funds tracked by Wall St. Rank held Evolent Health as of Q2 2024.

Based on Premier Fund Managers's 13F filing for Q2 2024, filed 13 Aug 2024.